Thus the combination of AFP and GPC3 could increase the sensitivity to 87.50% for HCC diagnosis while it was only 57.50% and 62.50% for AFP or GPC3, respectively (see Supplementary Table S4). This evidence concerns the gene AFP and hepatocellular carcinoma.